Literature DB >> 24899969

Hypermetabolic Axillary Mass on (18)F FDG PET/CT: Breast Cancer Arising from Accessory Breast Tissue.

Ji Sun Park1, Ah Young Lee1, Sang Gyun Bae1, Seok Mo Lee1.   

Abstract

Differential diagnosis among several causes of axillary malignant mass is important. The most common cause of palpable malignant axillary mass is metastatic lymphadenopathy. Although carcinoma arising from ectopic breast tissue is rare, the diagnosis should be kept in mind when evaluating malignant axillary mass. In this report we present a case with carcinoma arising from ectopic breast tissue. (18)F FDG PET/CT was performed for the purpose of localizing primary breast cancer lesion and systemic evaluation. PET/CT showed hypermetabolic lesions only in the right axilla. There is no evidence of malignancy in both breasts. When nuclear physicians encounter a hypermetabolic axillary mass indicating malignant lesion without evidence of primary breast malignant lesion, carcinoma arising from ectopic breast tissue should be included in the differential diagnosis.

Entities:  

Keywords:  Accessory breast tissue; Breast cancer; FDG PET/CT

Year:  2010        PMID: 24899969      PMCID: PMC4042916          DOI: 10.1007/s13139-010-0053-9

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  15 in total

1.  Sentinel node biopsy in ectopic breast cancer.

Authors:  O Gentilini; G Paganelli; G Trifiro; P Veronesi
Journal:  Nucl Med Commun       Date:  2003-11       Impact factor: 1.690

2.  Carcinoma of aberrant breast of the axilla.

Authors:  H D COGSWELL; E W CZERNY
Journal:  Am Surg       Date:  1961-05       Impact factor: 0.688

3.  Diagnosis and treatment of premalignant lesions of the breast.

Authors:  M M COPELAND; C F GESCHICKTER
Journal:  Surg Clin North Am       Date:  1950-12       Impact factor: 2.741

4.  Axillary metastases from unknown primary sites.

Authors:  E M Copeland; C M McBride
Journal:  Ann Surg       Date:  1973-07       Impact factor: 12.969

Review 5.  Carcinoma of the axillary breast.

Authors:  D M Evans; D P Guyton
Journal:  J Surg Oncol       Date:  1995-07       Impact factor: 3.454

6.  Carcinoma of aberrant breast tissue.

Authors:  J Petrek; P P Rosen; G F Robbins
Journal:  Clin Bull       Date:  1980

7.  Results of preliminary clinical trials of the positron emission mammography system PEM-I: a dedicated breast imaging system producing glucose metabolic images using FDG.

Authors:  K Murthy; M Aznar; C J Thompson; A Loutfi; R Lisbona; J H Gagnon
Journal:  J Nucl Med       Date:  2000-11       Impact factor: 10.057

8.  Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.

Authors:  N Avril; C A Rosé; M Schelling; J Dose; W Kuhn; S Bense; W Weber; S Ziegler; H Graeff; M Schwaiger
Journal:  J Clin Oncol       Date:  2000-10-15       Impact factor: 44.544

9.  The use of sentinel node biopsy in the treatment of cancer of an accessory breast.

Authors:  A L Thorne; A Jackson; C Yiangou
Journal:  Breast       Date:  2003-04       Impact factor: 4.380

10.  Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study.

Authors:  R S Brown; R L Wahl
Journal:  Cancer       Date:  1993-11-15       Impact factor: 6.860

View more
  1 in total

1.  Diagnosis and Treatment of Male Accessory Breast Cancer: A Comprehensive Systematic Review.

Authors:  Liwei Pang; Meiying Cui; Wanlin Dai; Shuodong Wu; Jing Kong
Journal:  Front Oncol       Date:  2021-03-29       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.